Concert Pharma names development head
This article was originally published in Scrip
Concert Pharmaceuticals has appointed Dr James V Cassella chief development officer. In the newly created role, Dr Cassella will lead Concert's product development strategy and operations and will have responsibility for all preclinical, clinical and manufacturing activities. Most recently, Dr Cassella was executive vice-president of R&D and chief scientific officer of Alexza Pharmaceuticals.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.